T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Cognex
CGNX
$10.4B
| $108M | 0.02% |
4,485,150
+497,196
| +12% | +$12.2M |
|
577
NorthWestern Energy
NWE
$4.4B
| $108M | 0.02% |
2,208,185
-16,840
| -0.8% | -$870K |
|
|
JNPR
578
DELISTED
Juniper Networks
JNPR
| $107M | 0.02% |
4,138,610
+1,048,280
| +34% | +$27.5M |
|
579
Urban Edge Properties
UE
$2.78B
| $107M | 0.02% |
5,146,816
+439,851
| +9% | +$9.9M |
|
|
TCO
580
DELISTED
Taubman Centers Inc.
TCO
| $107M | 0.02% |
1,537,404
+205,787
| +15% | +$15.2M |
|
|
MDCO
581
DELISTED
Medicines Co
MDCO
| $106M | 0.02% |
3,722,105
-123,800
| -3% | -$3.45M |
|
582
Telephone and Data Systems
TDS
$4.03B
| $106M | 0.02% |
3,613,844
-892,500
| -20% | -$25.6M |
|
583
MakeMyTrip
MMYT
$5.71B
| $106M | 0.02% |
5,396,884
-361,130
| -6% | -$7.54M |
|
584
Worthington Enterprises
WOR
$2.85B
| $106M | 0.02% |
5,707,743
+91,091
| +2% | +$1.55M |
|
|
ENDP
585
DELISTED
Endo International plc
ENDP
| $105M | 0.02% |
1,322,822
+194,200
| +17% | +$16.8M |
|
586
Petrobras Class A
PBR.A
$104B
| $105M | 0.02% |
12,906,489
-2,694,490
| -17% | -$22.5M |
|
587
Bright Horizons
BFAM
$3.85B
| $105M | 0.02% |
1,817,855
+161,659
| +10% | +$8.81M |
|
|
ISEE
588
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $105M | 0.02% |
2,011,408
+610,442
| +44% | +$30.4M |
|
|
CAVM
589
DELISTED
Cavium, Inc.
CAVM
| $104M | 0.02% |
1,505,830
-3,940
| -0.3% | -$276K |
|
590
Steris
STE
$23B
| $103M | 0.02% |
1,595,251
-22,850
| -1% | -$1.54M |
|
591
The Mosaic Company
MOS
$6.92B
| $103M | 0.02% |
2,193,853
-185,510
| -8% | -$8.42M |
|
|
SCU
592
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $103M | 0.02% |
840,244
-42,919
| -5% | -$5.47M |
|
593
America Movil
AMX
$69.8B
| $102M | 0.02% |
4,774,910
-165,850
| -3% | -$3.49M |
|
594
Perrigo
PRGO
$1.78B
| $102M | 0.02% |
550,152
+82,195
| +18% | +$15.7M |
|
595
Ryanair
RYAAY
$30.7B
| $101M | 0.02% |
3,442,223
-58,629
| -2% | -$1.63M |
|
|
NEWR
596
DELISTED
New Relic, Inc.
NEWR
| $101M | 0.02% |
2,858,351
+877,047
| +44% | +$28.6M |
|
|
PIR
597
DELISTED
Pier 1 Imports, Inc.
PIR
| $101M | 0.02% |
397,995
-9,998
| -2% | -$2.56M |
|
598
Phillips 66
PSX
$92.8B
| $100M | 0.02% |
1,243,201
+9,942
| +0.8% | +$790K |
|
599
Matthews International
MATW
$722M
| $99.8M | 0.02% |
1,878,090
-59,100
| -3% | -$3.01M |
|
|
XLRN
600
DELISTED
Acceleron Pharma
XLRN
| $99.6M | 0.02% |
3,147,643
-26,692
| -0.8% | -$861K |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.